August 15, 2017

ethoss® posts huge growth

[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_image _builder_version=”3.0.66″ src=”https://ethoss.dental/wp-content/uploads/2017/06/Contract-Signing-with-Ariston-Dental-Greece-2.jpg” show_in_lightbox=”off” url_new_window=”off” use_overlay=”off” sticky=”off” align=”left” always_center_on_mobile=”on” border_style=”solid” force_fullwidth=”off” /][et_pb_text _builder_version=”3.0.66″ background_layout=”light” text_orientation=”left” border_style=”solid”]

West Yorkshire-based ethoss® Regeneration Ltd has recorded an almost 200 per cent increase in turnover in just its second year of trading.

ethoss®, a dental company which specialises in a product which helps regenerate bone to support dental implants, recorded an increase in turnover of 187 per cent for the year 2016-17.

Following the launch of ethoss® in 2015, the company has achieved rapid growth in the UK and internationally – with distribution deals signed with partners in Ireland, Italy, Netherlands, Belgium and France in recent months.

The company has had to take on extra staff to cope with extra demand and is planning a further recruitment drive later this year.

ethoss® is a synthetic bone graft material used to help patients regenerate bone to support dental implants.

Unlike many other products on the market, ethoss® is completely free from any animal or human content and works extremely quickly – generating 50 per cent new bone for the patient after just 12 weeks.  This means surgical procedures can be completely more quickly and reliably, benefitting both patient and dentist.

Due to its innovative design, ethoss® doesn’t require an expensive separate collagen membrane to be used in the procedure. As well as reducing the overall cost to both dentist and patient, this helps to speed up healing times significantly.

Paul Harrison, Managing Director of ethoss® Regeneration, said: “ethoss® is a truly innovative solution which is benefiting both dentists and patients, so we are delighted to see the market moving towards synthetic technologies and a superior product.

“The pace of growth for ethoss® over the last 12 months has been outstanding. We continue to grow our market share in the UK and with the number of international partners we have signed up in recent months across Europe, we expect to see company growth accelerating at an even more rapid rate in the year ahead.

“Alongside our European success, this year we will focus on taking ethoss® to customers in the Middle East and Asia-Pacific regions, and we are already underway with the extensive regulatory process to get the product approved for sale in the USA – a significant investment for us.”

“We are very still relatively young as a company but we are excited to be taking this technology overseas and it is particularly encouraging to see growth in more established markets such as those in Western Europe.”